Cyto-Redoxin
B+
N+ Score83
Vitamins & MineralsServing: 1 Capsule(s)Type: Other Combinations

Cyto-Redoxin by Integrative Therapeutics is a combination supplement featuring Vitamin A, C, E, Zinc, Selenium, AnthoRedoxin(TM), NAC, and Alpha Lipoic Acid. It contains 11 scored ingredients, including 5 clinical doses. This product has an N+ Score of 83.

About This Product

Cyto-Redoxin by Integrative Therapeutics is a vitamins & minerals supplement containing 11 active ingredients. It has earned an N+ Score of 83/100 (Grade B+).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Vitamin A, Vitamin C, Vitamin E and 2 more.

N+ Score Breakdown

Ingredient Adequacy90/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness50/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity94/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +5 ingredient(s) at clinical dose levels
  • +Rich formula with 11 active ingredients

Weaknesses

  • No major weaknesses identified

Ingredient Analysis (11 ingredients)

IngredientAmountDose Adequacy
Vitamin A10000.000 IUHigh
Vitamin C500.000 mgOptimal
Vitamin E100.000 IUOptimal
Zinc7.500 mgAdequate
Selenium100.000 mcgOptimal
Total Carbohydrates1.000 gN/A
Alpha Lipoic Acid50.000 mgN/A
NAC150.000 mgN/A
natural Coenzyme Q1025.000 mgN/A
AnthoRedoxin(TM)500.000 mgN/A
Green tea (Camellia sinensis) (leaf) extract40.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.